Modulation of leukocyte-endothelial cell interaction and leukotriene dependent vasoconstriction by prostacyclin mimetics in the isolated rabbit heart

Advances in Experimental Medicine and Biology

Volumn 433, Issue , 1997, Pages 109-112

  Buccellati, Carola ^b   Rossoni, Giuseppe ^b   Berti, Ferruccio ^b   Folco, Giancarlo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONATE 5 LIPOXYGENASE; CALCIMYCIN; DEFIBROTIDE; ILOPROST; LYSINE ACETYLSALICYLATE; PEPTIDOLEUKOTRIENE; PROSTACYCLIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENDOTHELIUM CELL; HEART PROTECTION; HUMAN; HUMAN CELL; ICOSANOID METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED HEART; LEUKOCYTE; LEUKOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASOCONSTRICTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0031392692     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1810-9_22     Document Type: Article

References (12)

1. Berti F., Rossoni G., Magni F., Caruso D., Omini C., Puglisi L. and Galli G., 1988, Non-steroidal antiinflammatory drugs aggravate acute myocardial schemia in perfused rabbit heart; a role for prostacyclin, J Cardiovasc Pharmacol 12:438.
2. Dahlen S.E., Bjork J., Hedqvist P., Arfors K.E., Hammarstrom S., Lingren J.A. and Samuelsson B., 1981, Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules; in vivo effects with relevance to the acute inflammatory response, Proc Natl Acad Sci USA. 78: 3887.
3. 4 synthesized by polymorphonuclear leukocytes, J Bio Chem. 261:16466.
4. Lucchesi B.R. and Mullane K.M., 1986, Leukocytes and ischemia-induced myocardial injury, Annu Rev Pharmacol Toxicol. 26:201.
5. Maclouf J., Murphy R.C. and Henson P., 1989, Transcellular sulfidopeptide leukotriene biosynthetic capacity of vascular cells Blood, 74 (2):703.
6. Riva C.M., Morganroth M.J., Ljungman A.G., Schoeneich S.O., Marks R.M., Todd R.F., Ward P.A. and Boxer L.A., 1990, Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers, Am J Respir Cell Mol Biol. 3, 301.
7. Sala A., Aliev G.M. Rossoni G., Berti F., Buccellati C., Burnstock G., Folco G. and Maclouf J., 1996, Morphological and functional changes of coronary vasculature caused by transcellular biosynthesis of sulfidopeptide leukotrienes in isolated heart of rabbit, Blood, 87 (5): 1824.
8. Sala A., Rossoni G., Buccellati C., Berti F., Folco G. and Maclouf J.,1993, Formation of sulfidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit, Br J Pharmacol. 110:1206
9. Schrör K., Thiemermann C. and Lobel P., 1989, Stimulation of vascular prostacyclin formation by defibrotide: a new strategy for treatment of acute myocardial ischaemia, in: Limitation of Infarct Size, Schmutzler H, Rutsch W, Dougherty FC(eds). Berlin, Springer-Verlag p83.
10. Schrör K. Cytoprotective properties of prostacyclin, 1992, in:Prostacyclin: new perspectives for basic research and novel therapeutic indication, Rubanyi GM, Vane J(eds). Amsterdam: Elsevier, p157.
11. Simpson P.J., Mickelson J., Fantone J.C., Gallagher K.P., Lucchesi B.R., 1987, Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart, Circ Res. 60:666.
12. 2 analogue, ZK 36374:effects on myocardial preservation, collateral blood flow and infarct size, Cardiovasc Res. 18:163-173.